Ticker > Market > NSE > Nifty Pharma

Nifty Pharma

This page shows the latest information about the Nifty Pharma of NSE.

The Nifty Pharma Index contains total of companies which are also called its Constituents.

22662.7 
 +121.65  (.54%)
25 July 03:59 PM

Nifty Pharma 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Today's Gainer / Loser

Company priceRs. Change%
Cipla 1532.50 +3%
Torrent Pharma 3603.80 +2.38%
Dr. Reddy''s Lab 1277.90 +0.98%
Aurobindo Pharma 1122.80 +0.78%
JB Chem & Pharma 1708.00 +0.73%
Company priceRs. Change%
Divi''s Lab 6616.50 -0.03%
Ajanta Pharma 2784.30 -0.43%
Biocon 394.15 -0.87%
Granules India 469.10 -1.58%
Ipca Laboratories 1509.00 -2.06%

Top Performer companies (Based on TTM Profit)

Company TTM ProfitCr.
Sun Pharma Inds. 10980.10
Dr. Reddy''s Lab 5726.70
Cipla 5406.81
Zydus Lifesciences 4614.80
Aurobindo Pharma 3515.26
Lupin 3306.26
Alkem Laboratories 2216.00
Divi''s Lab 2191.00
Torrent Pharma 1911.25
Natco Pharma 1883.40

Top Return companies 1m 3m 6m 1Yr

Today's Nifty Pharma Price

As of the close of trading on 18th July 2025, the Nifty Pharma today closed at Rs. 22,592.75, marking a decline of 0.39% from its previous closing. The index saw some intraday volatility, reflecting ongoing market adjustments.

For the most current, regularly updated Nifty Pharma share price, please refer to the live ticker section located above on this page. That section provides a real-time share price summary, including the top gainer loser stocks daily. You can also view the Nifty Pharma index live chart for detailed intraday and historical movements.

Nifty Pharma Historical Returns

Here's a snapshot of the Nifty Pharma historical returns as of 18th July 2025:

  • 1 Day: -0.39%

     

  • 1 Week: +1.65%

  • 1 Month: +4.65%

  • 3 Months: +6.94%

  • 6 Months: +8.78%

  • 1 Year: +8.78%

The Nifty Pharma performance shows a slight dip in the very short term, aligning with the broader market's cautious sentiment. However, the index has demonstrated strong positive returns over the past week, month, three months, and six months, indicating sustained investor interest and robust performance within the sector. The one-year return also remains positive, highlighting the consistent growth trajectory of Indian pharmaceutical companies, despite periodic market fluctuations.

Nifty Pharma News and Updates

The Nifty Pharma index has been influenced by several key developments around mid-July 2025:

  • Positive Market Sentiment from Inflation Data: A significant factor providing underlying support to the market, including the pharma sector, was the retail inflation in India dropping to its lowest in over six years in June. This eased inflationary pressures and bolstered expectations of potential future rate cuts by the RBI, which generally bodes well for economic growth and consumer spending.

     

  • Mixed Corporate Earnings: While the broader market faced headwinds from weak banking sector earnings, some pharmaceutical companies within the Nifty Pharma stocks list have shown resilience. While no specific major pharma earnings were highlighted as exceptionally negative, the sector generally benefited from overall market stability and renewed buying interest on days when other sectors faced selling pressure.

  • Global Trade Dynamics and Sectoral Impact: While general market sentiment was impacted by global trade concerns and potential tariffs, the pharmaceutical sector often operates with a degree of insulation from such direct impacts, especially if a significant portion of their revenue is domestic or involves essential medicines. However, any broader global slowdown could indirectly affect export-oriented pharma companies.

  • Specific Stock Movements: Individual stocks within the Nifty Pharma index have seen varied performances. For instance, on July 17th, companies like Natco Pharma Ltd., Torrent Pharmaceuticals Ltd., and Mankind Pharma Ltd. were among the top gainers within the index, contributing to its positive movement on that day, even when the broader market was weak. Conversely, on July 18th, stocks like Aurobindo Pharma and Lupin saw declines. These individual movements reflect company-specific news, regulatory updates, or earnings expectations.

Read More
X